SCHEMBL23928884

SCHEMBL23928884

O=C(O)N1CC2(CC(O)c3ccccc3O2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 2/20 0.42
OPRD1 P41143 3/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
TP53 P04637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KMT2A Q03164 1/20 0.37
EPHX2 P34913 1/20 0.37
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12482018 0.86 SCD (0.49) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL23928887 0.81 IDO1 (0.47) SCD
SCHEMBL11244376 0.75 OPRD1 (0.47) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL15717425 0.75 OPRD1 (0.47) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL20109488 0.74 OPRD1 (0.46) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL12162414 0.74 OPRD1 (0.46) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL1115144 0.74 OPRD1 (0.46) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL5312276 0.72 KMT2A (0.62) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL16503896 0.72 KMT2A (0.46) SCDOPRD1HDAC3HDAC4HDAC1
SCHEMBL12481609 0.72 MEN1 (0.50) SCDOPRD1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 SCD 3246/4885OPRD1 85/4885HDAC3 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.